| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Institute of Biomedical Sciences (C.-S.C., C.-H.H., H.C., Y.-T.C., D.C., J.-J.C., Y.-C.C.,Y.-H.C., C.-C.C.), Academia Sinica, Taipei, Taiwan; Graduate Institute of Life Sciences (C.-H.H., C.-C.C.), National Defense Medical Center, Taipei, Taiwan; Center for Neural Science (H.-S.S.), Korea Institute of Science and Technology, Seoul, Korea; and Department of Physiology and Biophysics and Department of Neurology (K.P.C.), Howard Hughes Medical Institute, University of Iowa, Iowa City.
Correspondence to Chien-Chang Chen, Institute of Biomedical Sciences, Academia Sinica, 128 Academia Rd Sec 2, Nankang, Taipei 11529, Taiwan. E-mail ccchen{at}ibms.sinica.edu.tw
Voltage-gated T-type Ca2+ channels (T-channels) are normally expressed during embryonic development in ventricular myocytes but are undetectable in adult ventricular myocytes. Interestingly, T-channels are reexpressed in hypertrophied or failing hearts. It is unclear whether T-channels play a role in the pathogenesis of cardiomyopathy and what the mechanism might be. Here we show that the
1H voltage-gated T-type Ca2+ channel (Cav3.2) is involved in the pathogenesis of cardiac hypertrophy via the activation of calcineurin/nuclear factor of activated T cells (NFAT) pathway. Specifically, pressure overload–induced hypertrophy was severely suppressed in mice deficient for Cav3.2 (Cav3.2–/–) but not in mice deficient for Cav3.1 (Cav3.1–/–). Angiotensin II–induced cardiac hypertrophy was also suppressed in Cav3.2–/– mice. Consistent with these findings, cultured neonatal myocytes isolated from Cav3.2–/– mice fail to respond hypertrophic stimulation by treatment with angiotensin II. Together, these results demonstrate the importance of Cav3.2 in the development of cardiac hypertrophy both in vitro and in vivo. To test whether Cav3.2 mediates the hypertrophic response through the calcineurin/NFAT pathway, we generated Cav3.2–/–, NFAT-luciferase reporter mice and showed that NFAT-luciferase reporter activity failed to increase after pressure overload in the Cav3.2–/–/NFAT-Luc mice. Our results provide strong genetic evidence that Cav3.2 indeed plays a pivotal role in the induction of calcineurin/NFAT hypertrophic signaling and is crucial for the activation of pathological cardiac hypertrophy.
Key Words: hypertrophy cardiomyopathy T-type Ca2+ channel
This article has been cited by other articles:
![]() |
F. Pluteanu and L. L. Cribbs T-type calcium channels are regulated by hypoxia/reoxygenation in ventricular myocytes Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1304 - H1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kinoshita, K. Kuwahara, M. Takano, Y. Arai, Y. Kuwabara, S. Yasuno, Y. Nakagawa, M. Nakanishi, M. Harada, M. Fujiwara, et al. T-Type Ca2+ Channel Blockade Prevents Sudden Death in Mice With Heart Failure Circulation, September 1, 2009; 120(9): 743 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Houser Ca2+ Signaling Domains Responsible For Cardiac Hypertrophy and Arrhythmias Circ. Res., February 27, 2009; 104(4): 413 - 415. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |